Microrobotic swarms for cancer therapy
Cancer remains one of the most challenging diseases to treat, as conventional therapies like chemotherapy…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
GLP‑1 receptor agonist use and survival in older adults with cancer and type 2 diabetes
A large retrospective cohort study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated…
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment
Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple…
NICE recommends ribociclib for eligible HR+/HER2- early breast cancer patients at high risk of recurrence
Novartis Pharmaceuticals UK announced that the National Institute for Health and Care Excellence (NICE) has…
Researchers reveal how WEE1 drives cancer resistance to immunotherapy
Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some…
GALECTIN-3: a biomarker and therapeutic target in pancreatic adenocarcinoma
Pancreatic cancer is often diagnosed at an advanced stage and is characterised by a poor…
Embedded natural polysaccharides for intervention of pancreatic cancer development
Albizzia julibrissin is a widely distributed plant in China. Its dried stem bark has been used…
Scientists zero in on cellular mechanism fueling drug-resistant cancers
The mystery of how cancers develop resistance mechanisms and evade treatments that should have destroyed…
Researchers develop novel antibody-RNA therapy for resistant cancers
A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumours significantly shrank…
Temozolomide and radiation treatment lead to dramatic tumour shrinkage and improvement of hearing in an adult brainstem glioma patient with a rare IDH2 mutation
A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University,…